Literature DB >> 66114

Antigen specific lymphocyte activity in vitro by peripheral blood leucocytes from Mantoux positive and negative human beings. I. Comparison of quantitative and qualitative differences in the PPD-specific lymphoproliferative response of lymphocytes from the two kinds of donors.

B Jensen, M Kurpisz, B Rubin.   

Abstract

Lymphocytes from some PPD (purified protein derivative from tubercle bacillus) skin test negative (Mantoux negative=Mx--) human beings reacted against PPD in the lymphoproliferative assay with a time course and dose response very similar to those of lymphocytes from Mantoux positive (Mx+) individuals. Other Mx-- persons were PPD non-responsive in the lymphoproliferative assay. The PPD response of (immunoglobulin=Ig) Ig anti-Ig column passed lymphocytes (T-cells) from Mx--/LP+ (LP+=lymphoproliferative) persons was significantly reduced whereas the in vitro PPD response of T-lymphocytes from Mx+/LP+ was the same or increased. Purified B-lymphocytes from all kinds of tested individuals did not respond in vitro against PPD. Serological investigations indicated that one of the reasons for the negative skin reaction of individuals whose lymphocytes gave a positive lymphoproliferative response against PPD in vitro, is that such individuals had recirculating PPD of high molecular weight (greater than 900,000) and/or PPD anti-PPD antibody complexes in the serum. These substances could block the PPD-specific T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66114      PMCID: PMC1540790     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  The participation of thymus-derived and of bone marrow-derived lymphocytes of sensitized mice, in the proliferative response to specific antigen, in vitro.

Authors:  L Mugraby; I Gery; D Sulitzeanu
Journal:  Eur J Immunol       Date:  1974-06       Impact factor: 5.532

2.  Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes.

Authors:  M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

3.  In vitro correlates of hapten-specific delayed hypersensitivity.

Authors:  N Hanna; R W Ferraresi; S Leskowitz
Journal:  Cell Immunol       Date:  1973-07       Impact factor: 4.868

4.  Cellular and humoral antibody production against sheep erythrocytes in AKR mice. 1. Effect of antigen dose and treatment with 6-mercaptopurin on the primary immune response and on the development of immunological memory.

Authors:  B Rubin
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

5.  Modulation of in vitro lymphocyte transformation by antibodies: enhancement by antigen-antibody complexes and inhibition by antibody excess.

Authors:  J J Oppenheim
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

6.  The response of lymphocytes from tuberculin-positive or negative humans to various doses of PPD-tuberculin in vitro.

Authors:  B S Nilsson
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

7.  Defective in vitro spleen cell proliferative response to antigens in agammaglobulinemic chickens.

Authors:  H Kirchner; J J Oppenheim; M R Blaese; H J Hofstrand
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

8.  Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals.

Authors:  S D Douglas; R M Kamin; H H Fudenberg
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

9.  Regulation of helper cell activity by specifically adsorbable T lymphocytes.

Authors:  B Rubin
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

Review 10.  Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens.

Authors:  M Greaves; G Janossy; M Doenhoff
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  9 in total

1.  Human leucocyte responses in vitro. I. Transformation of purified T lymphocytes with and without addition of partially purified monocytes.

Authors:  G S Hansen; B Rubin; S F Sorensen
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.

Authors:  A W Bullen; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

3.  Proliferation of PPD-stimulated lymphocytes measured by sister chromatoid differential staining.

Authors:  P E Crossen; W F Morgan
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

4.  Tuberculin purified protein derivative-reactive T cells in cord blood lymphocytes.

Authors:  H Shiratsuchi; I Tsuyuguchi
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

5.  Random monocyte migration: an in vitro correlation with the delayed hypersensitivity skin reaction.

Authors:  C S Hawes; A S Kemp; W R Jones
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

6.  Circulating, Mycobacterium tuberculosis-specific lymphocytes from PPD skin test-negative patients with tuberculosis do not secrete interferon-gamma (IFN-gamma) and lack the cutaneous lymphocyte antigen skin-selective homing receptor.

Authors:  Z I Magnani; C Confetti; G Besozzi; L R Codecasa; P Panina-Bordignon; R Lang; G A Rossi; R Pardi; S E Burastero
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

7.  Antibody production and DNA synthesis of human lymphocyte subpopulations induced by PPD tuberculin.

Authors:  O Ringdén; B Rynnel-Dagöö; T Kunori; A Freijd; E Möller
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

8.  Evidence for a change in the expression of beta2-microglobulin-assoicated membrane structures on leukaemic human cells.

Authors:  T Plesner; H Karle; B Rubin; M Thomsen
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

9.  Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.

Authors:  H Repo; A A Kostiala; T U Kosunen
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.